1. Home
  2. INO vs WEA Comparison

INO vs WEA Comparison

Compare INO & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INO
  • WEA
  • Stock Information
  • Founded
  • INO 1979
  • WEA 2002
  • Country
  • INO United States
  • WEA United States
  • Employees
  • INO N/A
  • WEA N/A
  • Industry
  • INO Medical/Dental Instruments
  • WEA Trusts Except Educational Religious and Charitable
  • Sector
  • INO Health Care
  • WEA Finance
  • Exchange
  • INO Nasdaq
  • WEA Nasdaq
  • Market Cap
  • INO 69.3M
  • WEA 129.9M
  • IPO Year
  • INO 1998
  • WEA N/A
  • Fundamental
  • Price
  • INO $2.28
  • WEA $11.39
  • Analyst Decision
  • INO Buy
  • WEA
  • Analyst Count
  • INO 5
  • WEA 0
  • Target Price
  • INO $8.80
  • WEA N/A
  • AVG Volume (30 Days)
  • INO 2.2M
  • WEA 46.1K
  • Earning Date
  • INO 11-13-2025
  • WEA 01-01-0001
  • Dividend Yield
  • INO N/A
  • WEA 7.87%
  • EPS Growth
  • INO N/A
  • WEA N/A
  • EPS
  • INO N/A
  • WEA N/A
  • Revenue
  • INO $182,337.00
  • WEA N/A
  • Revenue This Year
  • INO N/A
  • WEA N/A
  • Revenue Next Year
  • INO $15,775.73
  • WEA N/A
  • P/E Ratio
  • INO N/A
  • WEA N/A
  • Revenue Growth
  • INO N/A
  • WEA N/A
  • 52 Week Low
  • INO $1.30
  • WEA $9.60
  • 52 Week High
  • INO $7.00
  • WEA $11.29
  • Technical
  • Relative Strength Index (RSI)
  • INO 51.05
  • WEA 80.71
  • Support Level
  • INO $2.33
  • WEA $11.11
  • Resistance Level
  • INO $2.98
  • WEA $11.18
  • Average True Range (ATR)
  • INO 0.22
  • WEA 0.08
  • MACD
  • INO -0.04
  • WEA 0.03
  • Stochastic Oscillator
  • INO 32.04
  • WEA 94.36

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

About WEA Western Asset Bond Fund Share of Beneficial Interest

Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.

Share on Social Networks: